NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,373 | -72.0% | 11,912 | -10.1% | 0.00% | -50.0% |
| Q4 2022 | $29,934 | -34.9% | 13,245 | -7.5% | 0.00% | -33.3% |
| Q3 2022 | $46,000 | -67.4% | 14,313 | -61.3% | 0.00% | -66.7% |
| Q2 2022 | $141,000 | -32.2% | 37,001 | -4.0% | 0.01% | 0.0% |
| Q1 2022 | $208,000 | -59.6% | 38,536 | +1.1% | 0.01% | -47.1% |
| Q4 2021 | $515,000 | -25.0% | 38,125 | -0.3% | 0.02% | -26.1% |
| Q3 2021 | $687,000 | -2.4% | 38,245 | -7.0% | 0.02% | -4.2% |
| Q2 2021 | $704,000 | -16.0% | 41,104 | -1.9% | 0.02% | -25.0% |
| Q1 2021 | $838,000 | +7.9% | 41,888 | -8.4% | 0.03% | -5.9% |
| Q4 2020 | $777,000 | +11.8% | 45,725 | +9.2% | 0.03% | -5.6% |
| Q3 2020 | $695,000 | -35.4% | 41,869 | -9.9% | 0.04% | -40.0% |
| Q2 2020 | $1,076,000 | +54.8% | 46,465 | +19.3% | 0.06% | +15.4% |
| Q1 2020 | $695,000 | -42.8% | 38,951 | -30.7% | 0.05% | -1.9% |
| Q4 2019 | $1,214,000 | +57.7% | 56,235 | +33.1% | 0.05% | +35.9% |
| Q3 2019 | $770,000 | -52.1% | 42,248 | -6.4% | 0.04% | -48.7% |
| Q2 2019 | $1,606,000 | -4.6% | 45,129 | -9.9% | 0.08% | -6.2% |
| Q1 2019 | $1,684,000 | +4.8% | 50,110 | +2.5% | 0.08% | -18.2% |
| Q4 2018 | $1,607,000 | -57.2% | 48,895 | -20.6% | 0.10% | -30.3% |
| Q3 2018 | $3,755,000 | +46.8% | 61,601 | +17.6% | 0.14% | +39.2% |
| Q2 2018 | $2,558,000 | -60.3% | 52,387 | -13.6% | 0.10% | -60.3% |
| Q1 2018 | $6,445,000 | +33.3% | 60,655 | -25.1% | 0.26% | +38.2% |
| Q4 2017 | $4,834,000 | +130.1% | 80,937 | -7.5% | 0.19% | +113.8% |
| Q3 2017 | $2,101,000 | +304.8% | 87,546 | +229.7% | 0.09% | +262.5% |
| Q2 2017 | $519,000 | -22.2% | 26,550 | -6.6% | 0.02% | -20.0% |
| Q1 2017 | $667,000 | +54.4% | 28,426 | -19.3% | 0.03% | +50.0% |
| Q4 2016 | $432,000 | +20.0% | 35,231 | +68.2% | 0.02% | +17.6% |
| Q3 2016 | $360,000 | +43.4% | 20,940 | +18.8% | 0.02% | +41.7% |
| Q2 2016 | $251,000 | -3.1% | 17,625 | -6.3% | 0.01% | -7.7% |
| Q1 2016 | $259,000 | -39.3% | 18,808 | -25.7% | 0.01% | -35.0% |
| Q4 2015 | $427,000 | +88.9% | 25,325 | +22.7% | 0.02% | +53.8% |
| Q3 2015 | $226,000 | -43.9% | 20,634 | -35.9% | 0.01% | -23.5% |
| Q2 2015 | $403,000 | -62.8% | 32,184 | -61.9% | 0.02% | -63.8% |
| Q2 2014 | $1,082,000 | -13.9% | 84,426 | -18.6% | 0.05% | -17.5% |
| Q1 2014 | $1,257,000 | +45.5% | 103,717 | +36.3% | 0.06% | +46.2% |
| Q4 2013 | $864,000 | +36.3% | 76,103 | +25.5% | 0.04% | +14.7% |
| Q3 2013 | $634,000 | -5.1% | 60,660 | +4.9% | 0.03% | -27.7% |
| Q2 2013 | $668,000 | – | 57,844 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |